Sibutramine-20mg 90 tablets
Sibutramine 20mg
Basic Information: The active ingredient in Sibutramine 20mg is sibutramine hydrochloride monohydrate. One tablet contains 20 mg of Sibutramine hydrochloride monohydrate. Brand names: Reductil, Reduce, Ectiva, Meridia, Sibutril, Lindaxa, and many others. Marketing authorization holder and manufacturer: Virtutis Pharma. Therapeutic use of Sibutramine: Sibutramine (also known as Sibutramine) is recommended for patients with nutritional obesity, in combination with a low-calorie diet and physical exercise. It helps reduce body weight by inducing a feeling of fullness after eating smaller amounts of food.
Properties:
Sibutramine is a serotonin and norepinephrine reuptake inhibitor. It works by affecting the reuptake of the neurotransmitters 5-hydroxytryptamine (known as serotonin) and norepinephrine into nerve cells in the brain. Neurotransmitters are chemical substances that allow nerve cells to communicate with each other. By blocking their reuptake, sibutramine increases the amount of these neurotransmitters in the brain. Increased levels of neurotransmitters in the brain help patients feel fuller after eating and help reduce their food intake. Sibutramine, in combination with diet and exercise, is used in severely obese patients with a body mass index (BMI) of 30 kg/m² or higher and in obese patients with a BMI of 27 kg/m² or higher who also have obesity-related risk factors such as type 2 diabetes or dyslipidemia (abnormal blood lipid levels). It has no addictive or psychostimulant effects.
Contraindications:
The product must not be used in cases of: – hypersensitivity to sibutramine or any other ingredient in the product; – severe eating disorders (anorexia or bulimia); – obesity caused by factors other than overeating (organic causes); – certain mental or neurological disorders (e.g., Tourette syndrome); – concurrent use of medications for sleep disorders, weight-loss drugs, antidepressants, and antipsychotics; – heart and blood vessel diseases; – high blood pressure (greater than 145/90 mm); – overactive thyroid (hyperthyroidism); – severe liver dysfunction; – severe kidney dysfunction; – enlarged prostate with urinary retention; – adrenal medullary tumor (pheochromocytoma); – glaucoma; – drug, medication, or alcohol addiction; – pregnancy and breastfeeding. Side effects occur mainly at the start of treatment during the first 4 weeks. Their frequency decreases over time. They are generally not serious, do not lead to discontinuation of treatment, and are temporary.Side effects include increased blood pressure, heart palpitations, dry mouth, constipation, and headaches.